Clinical Trial Update: Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)

View source ↗

Summary

A multicenter observational study evaluating a tumor-informed ctDNA MRD assay for molecular surveillance in early breast cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Molecular Surveillance, Breast Cancer | Status: WITHDRAWN